FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
GSK
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
Merck Is Coming for Pfizer’s Pneumonia Vaccine Market Share
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
U.K. Approves Covid-19 Booster Shot Aimed at Omicron
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...
Unilever Plans Job Cuts as Activist Investor Trian Takes Stake
Unilever UL 8.58% PLC plans to cut thousands of jobs as part of a reorganization aimed at speeding up its...
Unilever Walks Away From Glaxo Consumer-Healthcare Deal
Unilever UL 7.73% PLC said it wouldn’t increase its $68 billion offer for GlaxoSmithKline GSK -2.41% PLC’s consumer-healthcare business, effectively...
Unilever Makes Approach for Glaxo’s Consumer-Healthcare Business
LONDON— Unilever UL 1.14% PLC said it had approached GlaxoSmithKline GSK 0.91% PLC and Pfizer Inc. PFE -1.06% about an...
